Felipe Opazo
@opazo.bsky.social
PI at the Uni Medical Center Göttingen (UMG), Founder and CTO of NanoTag Biotechnologies. Using nanobodies for super-resolution microscopy in neurosciences. Opinions are my own.
See you, Christopher, in Rainiy Göttingen!
September 26, 2025 at 5:12 PM
See you, Christopher, in Rainiy Göttingen!
Yes, it might be that in some synaptic type, other synaptotagmin isoforms are more dominant, but it is far from demonstrated that there is NO Syt1 in such synapses...
May 27, 2025 at 5:58 AM
Yes, it might be that in some synaptic type, other synaptotagmin isoforms are more dominant, but it is far from demonstrated that there is NO Syt1 in such synapses...
Try our anti-Synaptotagmin1 #nanobody, then you label endogenous targets without adding extra copies of anything synaptic. We can send you the AAV plasmids. Check paper here: onlinelibrary.wiley.com/doi/10.1002/...
A Versatile Synaptotagmin‐1 Nanobody Provides Perturbation‐Free Live Synaptic Imaging And Low Linkage‐Error in Super‐Resolution Microscopy
Selection, characterization, and development of a nanobody that strongly and selectively binds the C2A domain of synaptotagmin-1, providing unparalleled imaging accuracy in various super-resolution i...
onlinelibrary.wiley.com
May 26, 2025 at 5:13 PM
Try our anti-Synaptotagmin1 #nanobody, then you label endogenous targets without adding extra copies of anything synaptic. We can send you the AAV plasmids. Check paper here: onlinelibrary.wiley.com/doi/10.1002/...
Congrats, nice work! Clever use of the ALFA system!
May 16, 2025 at 2:07 PM
Congrats, nice work! Clever use of the ALFA system!